EFL

Cohort Year: 2023-2024

Tracks: Life Sciences

VISIT WEBSITE

Tezcat Biosciences

Tezcat Biosciences is developing a receptor-independent drug delivery technology to provide treatment alternatives for patients harboring RAS-activated cancers.